GTx-024: Clinical Trials

2 trials of GTx-024, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow GTx-024: new trials by email Literature Review of GTx-024 trials Research Report on GTx-024

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
GTx-024, placebo - Muscle Wasting, Non-Small Cell Lung Cancer
Phase 3CompletedGTx3302011-07-012020-11-09
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
GTx-024, placebo - Muscle Wasting, Non Small Cell Lung Cancer
Phase 3CompletedGTx3212011-07-012016-03-03

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Muscular Atrophy (2)

Sponsors

GTx (2)

Countries

United States (2)

Results publications

PMID 27138015